Lee Sung 4
4 · Vir Biotechnology, Inc. · Filed Mar 29, 2023
Insider Transaction Report
Form 4
Lee Sung
Chief Financial Officer
Transactions
- Award
Common Stock
2023-03-27+66,500→ 66,500 total - Award
Stock Option (Right to Buy)
2023-03-27+133,000→ 133,000 totalExercise: $23.01Exp: 2033-03-26→ Common Stock (133,000 underlying)
Footnotes (2)
- [F1]Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
- [F2]25% of the shares subject to the stock option vest and become exercisable on March 27, 2024, and the remainder vest in 36 equal monthly installments thereafter.